126 related articles for article (PubMed ID: 23240859)
1. The effect of a preoperative erythropoietin protocol as part of a multifaceted blood management program in daily clinical practice (CME).
Doodeman HJ; van Haelst IM; Egberts TC; Bennis M; Traast HS; van Solinge WW; Kalkman CJ; van Klei WA
Transfusion; 2013 Sep; 53(9):1930-9. PubMed ID: 23240859
[TBL] [Abstract][Full Text] [Related]
2. Perioperative intravenous iron, with or without erythropoietin, plus restrictive transfusion protocol reduce the need for allogeneic blood after knee replacement surgery.
Cuenca J; García-Erce JA; Martínez F; Pérez-Serrano L; Herrera A; Muñoz M
Transfusion; 2006 Jul; 46(7):1112-9. PubMed ID: 16836557
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic blood transfusion reduction by risk-based protocol in total joint arthroplasty.
Rashiq S; Jamieson-Lega K; Komarinski C; Nahirniak S; Zinyk L; Finegan B
Can J Anaesth; 2010 Apr; 57(4):343-9. PubMed ID: 20099050
[TBL] [Abstract][Full Text] [Related]
4. Preoperative erythropoietin alpha reduces postoperative transfusions in THA and TKA but may not be cost-effective.
Bedair H; Yang J; Dwyer MK; McCarthy JC
Clin Orthop Relat Res; 2015 Feb; 473(2):590-6. PubMed ID: 25106796
[TBL] [Abstract][Full Text] [Related]
5. An individualized pre-operative blood saving protocol can increase pre-operative haemoglobin levels and reduce the need for transfusion in elective total hip or knee arthroplasty.
Gonzalez-Porras JR; Colado E; Conde MP; Lopez T; Nieto MJ; Corral M
Transfus Med; 2009 Feb; 19(1):35-42. PubMed ID: 19302453
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of preoperative recombinant human erythropoietin administration for reducing transfusion requirements in patients undergoing surgery for hip fracture repair. An observational cohort study.
García-Erce JA; Cuenca J; Haman-Alcober S; Martínez AA; Herrera A; Muñoz M
Vox Sang; 2009 Oct; 97(3):260-7. PubMed ID: 19497085
[TBL] [Abstract][Full Text] [Related]
7. Implementing a blood management protocol during the entire perioperative period allows a reduction in transfusion rate in major orthopedic surgery: a before-after study.
Rineau E; Chaudet A; Chassier C; Bizot P; Lasocki S
Transfusion; 2016 Mar; 56(3):673-81. PubMed ID: 26748489
[TBL] [Abstract][Full Text] [Related]
8. [Effect of preoperative treatment with recombinant human erythropoietin in patients undergoing hemodilutional autologous transfusion].
Nakae Y; Sonoda H; Miyabe M; Kawamata M; Sakakibara N; Kawana S; Namiki A
Masui; 1995 Oct; 44(10):1362-8. PubMed ID: 8538004
[TBL] [Abstract][Full Text] [Related]
9. Preoperative haematinics and transfusion protocol reduce the need for transfusion after total knee replacement.
Cuenca J; García-Erce JA; Martínez F; Cardona R; Pérez-Serrano L; Muñoz M
Int J Surg; 2007 Apr; 5(2):89-94. PubMed ID: 17448971
[TBL] [Abstract][Full Text] [Related]
10. The effectiveness of a de-implementation strategy to reduce low-value blood management techniques in primary hip and knee arthroplasty: a pragmatic cluster-randomized controlled trial.
Voorn VMA; Marang-van de Mheen PJ; van der Hout A; Hofstede SN; So-Osman C; van den Akker-van Marle ME; Kaptein AA; Stijnen T; Koopman-van Gemert AWMM; Dahan A; Vliet Vlieland TPMM; Nelissen RGHH; van Bodegom-Vos L
Implement Sci; 2017 May; 12(1):72. PubMed ID: 28558843
[TBL] [Abstract][Full Text] [Related]
11. Benefits of postoperative shed blood reinfusion in patients undergoing unilateral total knee replacement.
Muñoz M; Ariza D; Garcerán MJ; Gómez A; Campos A
Arch Orthop Trauma Surg; 2005 Jul; 125(6):385-9. PubMed ID: 15821894
[TBL] [Abstract][Full Text] [Related]
12. Retrospective observational study of patients with chemotherapy-related anemia receiving erythropoietic agents.
Mark TL; McKenzie RS; Fastenau J; Piech CT
Curr Med Res Opin; 2005 Sep; 21(9):1347-54. PubMed ID: 16197652
[TBL] [Abstract][Full Text] [Related]
13. Cost minimization analysis of preoperative erythropoietin vs autologous and allogeneic blood donation in total joint arthroplasty.
Green WS; Toy P; Bozic KJ
J Arthroplasty; 2010 Jan; 25(1):93-6. PubMed ID: 19056224
[TBL] [Abstract][Full Text] [Related]
14. Preoperative erythropoietin within a patient blood management program decreases both blood transfusion and postoperative anemia: a prospective observational study.
Biboulet P; Motais C; Pencole M; Karam O; Dangelser G; Smilevitch P; Maissiat G; Capdevila X; Bringuier S
Transfusion; 2020 Aug; 60(8):1732-1740. PubMed ID: 32681743
[TBL] [Abstract][Full Text] [Related]
15. [Erythropoietin alone or as an adjuvant for the autologous blood donation program in major orthopedic surgery].
Bisbe E; Sáez M; Nomen N; Castillo J; Santiveri X; Mestre C; Cano X
Rev Esp Anestesiol Reanim; 2003 Oct; 50(8):395-400. PubMed ID: 14601367
[TBL] [Abstract][Full Text] [Related]
16. Outcomes in Patients Undergoing Cardiac Surgery Who Decline Transfusion and Received Erythropoietin Compared to Patients Who Did Not: A Matched Cohort Study.
Duce L; Cooter ML; McCartney SL; Lombard FW; Guinn NR
Anesth Analg; 2018 Aug; 127(2):490-495. PubMed ID: 28857800
[TBL] [Abstract][Full Text] [Related]
17. Occurrence and determinants of poor response to short-term pre-operative erythropoietin treatment.
van Haelst IM; Egberts AC; Doodeman HJ; van Solinge WW; Kalkman CJ; Bennis M; Traast HS; van Klei WA
Acta Anaesthesiol Scand; 2013 Mar; 57(3):350-7. PubMed ID: 23186063
[TBL] [Abstract][Full Text] [Related]
18. Which patients are more likely to benefit from postoperative shed blood salvage after unilateral total knee replacement? An analysis of 581 consecutive procedures.
Muñoz M; Kühlmorgen B; Ariza D; Haro E; Marroquí A; Ramirez G
Vox Sang; 2007 Feb; 92(2):136-41. PubMed ID: 17298576
[TBL] [Abstract][Full Text] [Related]
19. [A strategy for reduction of blood loss in total hip joint endoprosthesis].
Svagr M
Acta Chir Orthop Traumatol Cech; 2002; 69(4):229-35. PubMed ID: 12362625
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin in the management of patients with nonhematologic cancer receiving chemotherapy. Systemic Treatment Program Committee.
Quirt I; Micucci S; Moran LA; Pater J; Browman G
Cancer Prev Control; 1997 Aug; 1(3):241-8. PubMed ID: 9765749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
